Your Health, We Care
Release date: 2024-07-10 14:39:59 Recommended: 97
Lorlatinib is used as a first-line treatment for patients with anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC). In the critical phase III CROWN study, for ALK positive NSCLC patients who had not received prior treatment, loratinib reduced the risk of disease progression or death by 72% compared to the clotozantinib group.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：207Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：220Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：192Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：158Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：290Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：170Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：326Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：196Release date: 2024-07-09
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) ···【more】
Recommended：154Release date: 2025-01-13
Recent advancements have reaffirmed the significance of liquid biopsy in the man···【more】
Recommended：151Release date: 2025-01-06
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Fo···【more】
Recommended：166Release date: 2024-12-30
The new indication involves the treatment of adult patients with locally advance···【more】
Recommended：157Release date: 2024-12-24
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont···【more】
Recommended：143Release date: 2024-12-17
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-C···【more】
Recommended：104Release date: 2024-12-13
